A detailed history of Whittier Trust CO transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Whittier Trust CO holds 1,474 shares of CRSP stock, worth $76,087. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,474
Previous 1,474 -0.0%
Holding current value
$76,087
Previous $79,000 12.66%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

BUY
$51.17 - $68.18 $40,936 - $54,544
800 Added 118.69%
1,474 $79,000
Q4 2022

Jan 25, 2023

BUY
$39.19 - $65.67 $18,262 - $30,602
466 Added 224.04%
674 $0
Q1 2022

Apr 29, 2022

BUY
$53.19 - $79.24 $478 - $713
9 Added 4.52%
208 $13,000
Q4 2021

Jan 19, 2022

SELL
$70.09 - $111.29 $64,763 - $102,831
-924 Reduced 82.28%
199 $15,000
Q1 2021

Apr 26, 2021

BUY
$110.72 - $210.04 $102,305 - $194,076
924 Added 464.32%
1,123 $137,000
Q2 2018

Jul 27, 2018

BUY
$42.62 - $73.59 $8,481 - $14,644
199 New
199 $12,000

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $4.03B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Whittier Trust CO Portfolio

Follow Whittier Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Whittier Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Whittier Trust CO with notifications on news.